Skip to main content
SpringerLink
Log in

Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

The detection of multisystemic involvement often leads to a correct diagnosis of the antiphospholipid syndrome (APS), even in cases with predominant neurologic manifestations. However, when central nervous system deficits are isolated and have a relapsing-remitting or a progressive course, other conditions must be carefully considered. In this context, the diagnostic accuracy of conventional magnetic resonance imaging (MRI) is hampered by its limited pathologic specificity, which is one of the reasons why no or only modest correlations have been found between the burden of MRI-visible lesions and other clinical or laboratory measures of disease severity in patients with APS. Neuroimaging techniques with a higher pathologic specificity than conventional MRI show promise in achieving diagnostic confidence earlier in the course of APS and in better monitoring the efficacy of therapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Thiagarajan P, Shapiro SS, De Marco L: Monoclonal immunoglobulin (MI) coagulation inhibitor with phospholipid specificity: mechanisms of a lupus anticoagulant. J Clin Invest 1980, 66:397–405.

    Article  PubMed  CAS  Google Scholar 

  2. Harris EN: Antiphospholipid syndrome. In Rheumatology. Edited by Klippel JH, Dieppe PA. London: Mosby; 1998:1–6.

    Google Scholar 

  3. Khamashta MA, Hughes GR: Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995, 7:389–394.

    Article  PubMed  CAS  Google Scholar 

  4. Levine SR, Brey RL: Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996, 5:347–353.

    PubMed  CAS  Google Scholar 

  5. Brey RL, Escalante A: Neurological manifestations of antiphospholipid antibody syndrome. Lupus 1998, 7:S67-S74.

    Article  PubMed  Google Scholar 

  6. Alarcon-Segovia D, Cabral AR: The concept and classification of antiphospholipid/cofactor syndromes. Lupus 1996, 5:364–367.

    PubMed  CAS  Google Scholar 

  7. Lockshin MD, Sammaritano LR, Schwartzman S: Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000, 43:440–443.

    Article  PubMed  CAS  Google Scholar 

  8. Rovaris M, Filippi M: The value of new magnetic resonance techniques in multiple sclerosis. Curr Opin Neurol 2000, 13:249–254.

    Article  PubMed  CAS  Google Scholar 

  9. Fazekas F, Barkhof F, Filippi M, et al.: The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999, 53:448–456. This paper summarizes the results of a review made by a task force of the North Atlantic Collaboration in MS about the use of MRI as a diagnostic tool for MS in the clinical practice. Recommendations are reported for indications for referral for diagnostic MRI studies, imaging protocols, and interpretations of MRI findings for MS diagnosis. This review also provides useful information for the optimization and standardization of MRI protocols for a differential diagnosis between APS and MS.

    PubMed  CAS  Google Scholar 

  10. Fieschi C, Rasura M, Anzini A, Beccia M: Central nervous system vasculitis. J Neurol Sci 1998, 153:159–171.

    Article  PubMed  CAS  Google Scholar 

  11. Filippi M, Grossman RI, Comi G: Magnetization transfer in multiple sclerosis. Neurology 1999, 53:S18-S22.

    PubMed  CAS  Google Scholar 

  12. McGowan JC: Magnetic resonance spectroscopy: fundamentals. In Magnetic Resonance Spectroscopy in Multiple Sclerosis. Edited by Filippi M, Arnold DL, Comi G. Milan: Springer-Verlag; 2001:33–49.

    Google Scholar 

  13. Weingarten K, Filippi C, Barbut D, Zimmerman RD: The neuroimaging features of the cardiolipin antibody syndrome. Clin Imaging 1997, 21:6–12.

    Article  PubMed  CAS  Google Scholar 

  14. Asherson RA, Khamashta MA, Gil A, et al.: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989, 86:391–399.

    Article  PubMed  CAS  Google Scholar 

  15. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV: Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984, 2:47–51.

    PubMed  CAS  Google Scholar 

  16. Cervera R, Asherson RA, Font J, et al.: Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine 1997, 76:203–212.

    Article  PubMed  CAS  Google Scholar 

  17. Bell CL, Partington C, Robbins M, et al.: Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991, 34:432–441.

    Article  PubMed  CAS  Google Scholar 

  18. Hachulla E, Michon Pasturel U, Leys D, et al.: Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998, 7:124–131. The prevalence of brain MRI abnormalities and their relationship with aPL was studied in patients with SLE or primary APS. Focal infarcts did not differ in the SLE group when compared with the APS group. In both groups, the burden of MRI lesions was significantly higher in patients experiencing neurologic symptoms. A weak, but significant, correlation was found between brain atrophy and LA. These results indicate that the severity of brain MRI abnormalities does not depend on the presence of aPL in SLE and primary APS.

    Article  PubMed  CAS  Google Scholar 

  19. Rovaris M, Viti B, Ciboddo G, et al.: Brain involvement in systemic immune-mediated diseases: a magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatry 2000, 68:170–177. Brain MRI and MTI findings were compared in patients with MS and other SID affecting the CNS, including SLE and primary APS. The patterns of T2-weighted MRI abnormalities did not differ in the various conditions, even though the lesion burden was significantly higher in MS than in any type of SID. MTI findings indicated that, in APS, brain tissue damage at a microscopic level was negligible, even in the presence of macroscopic MRI lesions. These results suggest that combined use of MRI and MTI is promising for increasing the confidence when making a differential diagnosis between MS, neuropsychiatric SLE, and APS.

    Article  PubMed  CAS  Google Scholar 

  20. Sailer M, Burchert W, Ehrenheim C, et al.: Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J Neurol 1997, 244:186–193.

    Article  PubMed  CAS  Google Scholar 

  21. Amoroso A, Del Porto F, Garzia P, et al.: Primary antiphospholipid syndrome and cerebral atrophy: a rare association? Am J Med Sci 1999, 317:425–428.

    Article  PubMed  CAS  Google Scholar 

  22. Cuadrado MJ, Khamashta MA, Ballesteros A, et al.: Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine 2000, 79:57–68. This retrospective study analyzed the clinical, laboratory, and imaging findings of MS-like expression in patients with APS and compared them with findings from patients with definite MS. The aim of the study was to identify useful parameters for a differential diagnosis between these two conditions. Even though the average burden of MRI lesions was higher in the MS than in the APS group, no criteria were found for distinguishing patients with APS from those with MS.

    Article  PubMed  CAS  Google Scholar 

  23. Ijdo JW, Conti Kelly AM, Greco P, et al.: Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 1999, 8:109–115.

    Article  PubMed  CAS  Google Scholar 

  24. Karussis D, Leker RR, Ashkenazi A, Abramsky O: A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998, 44:629–634. A group of patients diagnosed with definite or probable MS who were consistently positive for aPL was observed for 1 to 3 years and underwent MRI evaluation. MRI features consistent with MS were found in all but one patient, whereas CSF abnormalities were detected in approximately 10% of them. In most of the patients, the clinical picture consisted of slowly progressive myelopathy, with or without concomitant optic neuropathy, often associated with persistent headache. The authors conclude that, in these patients, other (presumably vascular) mechanisms may be involved in the pathogenesis of the neurologic symptoms. Consequently, their management should include antiplatelet or anticoagulant agents.

    Article  PubMed  CAS  Google Scholar 

  25. Tourbah A, Piette JC, Iba Zizen MT, et al.: The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997, 54:53–60.

    PubMed  CAS  Google Scholar 

  26. Hajnal JV, De Coene B, Lewis PD, et al.: High signal regions in normal white matter shown by heavily T2-weighted CSF nulled IR sequences. J Comput Assist Tomogr 1992, 16:506–513.

    Article  PubMed  CAS  Google Scholar 

  27. Gawne-Cain ML, O’Riordan JI, Thompson AJ, Moseley IF, Miller DH: Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin echo. Neurology 1997, 49:364–370.

    PubMed  CAS  Google Scholar 

  28. Rovaris M, Inglese M, Viti B, et al.: The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases. J Neurol 2000, 247:29–33.

    Article  PubMed  CAS  Google Scholar 

  29. van Walderveen MAA, Kamphorst W, Scheltens P, et al.: Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998, 50:1282–1288.

    PubMed  Google Scholar 

  30. Katz D, Taubenberger JK, Cannella B, et al.: Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993, 34:661–669.

    Article  PubMed  CAS  Google Scholar 

  31. Uhlenbrock D, Sehlen S: The value of T1-weighted images in the differentiation between MS, white matter lesions and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology 1989, 31:203–212.

    Article  PubMed  CAS  Google Scholar 

  32. Campi A, Filippi M, Comi G, Scotti G: Recurrent acute transverse myelopathy associated with anticardiolipin antibodies. AJNR Am J Neuroradiol 1998, 19:781–786.

    PubMed  CAS  Google Scholar 

  33. Provenzale JM, Barboriak DP, Gaensler EH, et al.: Lupus-related myelitis: serial MR findings. AJNR Am J Neuroradiol 1994, 15:1911–1917.

    PubMed  CAS  Google Scholar 

  34. Yoshioka H, Matsubara T, Miyanomae Y, et al.: Spinal cord MRI in neuro-BehÇet disease. Neuroradiology 1996, 38:661–662.

    Article  PubMed  CAS  Google Scholar 

  35. Rovaris M, Viti B, Ciboddo G, Capra R, Filippi M: Cervical cord MRI findings in systemic immune-mediated diseases. J Neurol Sci 2000, 176:128–130.

    Article  PubMed  CAS  Google Scholar 

  36. Rocca MA, Mastronardo G, Horsfield MA, et al.: Comparison of three MR sequences for the detection of cervical cord lesions in multiple sclerosis. AJNR Am J Neuroradiol 1999, 20:1710–1716.

    PubMed  CAS  Google Scholar 

  37. Lycklama à Nijeholt GJ, van Walderveen MAA, Castelijns JA, et al.: Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998, 121:687–697.

    Article  Google Scholar 

  38. Brochet B, Dousset V: Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 1999, 53:S12-S17.

    PubMed  CAS  Google Scholar 

  39. Filippi M, Campi A, Dousset V, et al.: A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995, 45:478–482.

    PubMed  CAS  Google Scholar 

  40. Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA: Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum 2000, 43:48–54.

    Article  PubMed  CAS  Google Scholar 

  41. Rocca MA, Colombo B, Pratesi A, Comi G, Filippi M: A magnetization transfer imaging study of the brain in patients with migraine. Neurology 2000, 54:507–509.

    PubMed  CAS  Google Scholar 

  42. De Stefano N, Federico A: Overview of magnetic resonance spectroscopy studies in white matter diseases other than multiple sclerosis. In Magnetic Resonance Spectroscopy in Multiple Sclerosis. Edited by Filippi M, Arnold DL, Comi G. Milan: Springer-Verlag; 2001:121–133.

    Google Scholar 

  43. Sabet A, Sibbitt WL, Stidley CA, Danska J, Brooks WM: Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998, 29:2254–2260. Using MRS, the neurometabolic pattern of brain injury was investigated in SLE patients with or without secondary APS. Strokes and elevated aPL were more common in SLE patients with APS than in those without. In the former group of patients, NAA/Cr was lower and Cho/Cr was higher. Decreased NAA/Cr was more closely related to aPL than the presence of stroke or APS. These findings indicate that antiphospholipid antibodies are associated with an increased risk for brain damage (independent of the presence of APS), possibly acting through a direct, immunemediated injury of CNS cellular components.

    PubMed  CAS  Google Scholar 

  44. Greenberg JO: Neuroimaging, edn 2. New York: McGraw-Hill; 1999.

    Google Scholar 

  45. Kato T, Morita A, Matsumoto Y: Hypoperfusion of brain single photon emission computerized tomography in patients with antiphospholipid antibodies. J Dermatol Sci 1997, 14:20–28. Patients with aPL positivity who complained of only mild headache in the absence of clinical or MRI evidence of CNS abnormalities were observed using brain SPECT. Focal low perfusion areas or nonuniform isotope uptake were found in all patients. These findings indicate that brain SPECT may be useful to detect cerebral abnormalities in the early phases of APS.

    Article  PubMed  CAS  Google Scholar 

  46. Hilker R, Thiel A, Geisen C, Rudolf J: Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. Lupus 2000, 9:311–316.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute and University H San Raffaele, via Olgettina 60, 20132, Milan, Italy

    Marco Rovaris MD, Carla Pedroso MD & Massimo Filippi MD

Authors
  1. Marco Rovaris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carla Pedroso MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Filippi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rovaris, M., Pedroso, C. & Filippi, M. Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome. Curr Rheumatol Rep 3, 301–306 (2001). https://doi.org/10.1007/s11926-001-0034-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-001-0034-1

Keywords

Search

Navigation